Zhuqing Liu

Title: Innovations and Contributions of Inventor Zhuqing Liu

Introduction

Zhuqing Liu is a prominent inventor based in Edison, NJ (US), known for his significant contributions to the field of biocatalysis and pharmaceutical processes. With a total of 17 patents to his name, Liu has made remarkable advancements in the preparation of beta 3 agonists and their intermediates.

Latest Patents

Liu's latest patents include a process for preparing beta 3 agonists and intermediates. This application focuses on efficient and economical methods for synthesizing beta 3 agonists of the formula I-7, along with intermediate compounds essential for their production. The disclosure emphasizes the use of ketoreductase (KRED) biocatalyst enzymes, showcasing innovative methods for utilizing these biocatalysts in the synthesis process. Another notable patent involves a multi-step reaction process for preparing a compound of formula I-11, further demonstrating Liu's expertise in this area.

Career Highlights

Throughout his career, Zhuqing Liu has worked with esteemed organizations such as Merck Sharp & Dohme Corp. and the University of Pennsylvania. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Liu has collaborated with notable colleagues, including Feng Xu and Kevin Campos, enhancing the scope and impact of his research endeavors.

Conclusion

Zhuqing Liu's innovative work in the preparation of beta 3 agonists and his extensive patent portfolio highlight his significant contributions to the field of biocatalysis. His career reflects a commitment to advancing pharmaceutical processes through collaboration and innovation.